The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …

Abstract The Global Initiative for Asthma (GINA) was established in 1993 by the World
Health Organization and the US National Heart Lung and Blood Institute to improve asthma …

Importance Asthma is a major public health problem worldwide and is associated with
excess morbidity, mortality, and economic costs associated with lost productivity. The …

Asthma is a heterogeneous lung disease, usually characterised by chronic airway
inflammation. Although evidence-based treatments are available in most countries, asthma …

Asthma is highly prevalent and sometimes deadly, especially in certain groups. The 2019
Global Initiative for Asthma (GINA) guidelines recommend that all asthma patients be treated …

Abstract Background The 2021 Global Initiative for Asthma (GINA) report recommends as-
needed inhaled corticosteroid (ICS)/formoterol irrespective of severity, and maintenance and …

Background This asthma guideline update focuses on the management of individuals with
asthma at the mild end of the spectrum. It applies to children 1 year of age and over and …

The 2020 National Asthma Education and Prevention Program Coordinating Committee
Expert Panel Working Group (NAEPP [2020 Focused Asthma Update]) guidelines and the …

For years, standard asthma treatment has included short acting beta agonists (SABA),
including as monotherapy in patients with mild asthma symptoms. In the Global Initiative for …

Background The Global Initiative for Asthma recommends as-needed inhaled corticosteroid
(ICS)-formoterol as an alternative to maintenance ICS plus short-acting β2-agonist (SABA) …